Sign in Subscribe

Tegoprubart Trial: Six Type 1 Diabetes Patients Achieve Insulin Independence Without Toxic Side Effects

Eledon’s (ELDN) tegoprubart helps Type 1 diabetes patients achieve insulin independence after islet transplants without harsh side effects of current medications.

Tegoprubart Trial: Six Type 1 Diabetes Patients Achieve Insulin Independence Without Toxic Side Effects
Credit: Eledon Pharmaceuticals
Already have an account? Sign in.